In a recent CRO industry discussion, Mary Gunn - Board Advisor & Non-Executive Director - shared her perspective on how Contract Research Organizations are evolving under rising delivery pressure, regulatory intensity, and sponsor expectations. Having led global CRO organizations as CEO, COO, and CBO, and earlier worked in sponsor-side drug development and strategy roles, Mary brings a cross-market view of how partnership, talent, and operating models are changing.

“If I’m going to make a very bold prediction - the next decade is going to favor fewer, more integrated CRO platforms. Execution credibility is different from scale alone, and that’s what will drive value.” - Mary Gunn, Board Advisor & Non-Executive Director

From outsourcing for capacity, to outsourcing for risk

From Mary’s perspective, the CRO model has fundamentally shifted over the past decade. Sponsors no longer outsource primarily for cost or capacity - they outsource to manage risk and protect timelines. CROs are now expected to provide execution stability, absorb operational volatility, and maintain inspection-ready standards even under disruption. She notes that partnership language has become more common because expectations are genuinely deeper: sponsors want delivery partners, not task vendors.

Rising sponsor expectations and accountability

Mary emphasizes that sponsors increasingly want fewer vendors and clearer accountability. Capital discipline, portfolio prioritization, and more complex trial designs are pushing CROs to operate with stronger governance and ownership. In her view, the differentiator is not scale alone but execution credibility - the ability to lead programs reliably under uncertainty and make disciplined decisions when conditions shift.

Where leadership truly differentiates

According to Mary, the talent gap is not technical - it is operational. The market has many narrow specialists but too few leaders who can scale teams, manage ambiguity, and engage credibly with sponsors at senior level. She stresses that technical competence is now assumed, while real differentiation comes from judgment, cross-functional awareness, and decision-making under pressure. Exceptional leaders consistently connect their work to sponsor priorities around timelines, cost, and risk.

Technology supports - it doesn’t replace - operators

Mary sees AI and advanced analytics improving feasibility, enrollment prediction, and risk monitoring, but she is clear that technology does not replace experienced operators. Productivity may increase, but accountability does not shift. She believes the advantage will go to organizations that build digital fluency into leadership roles and centralize data governance, enabling faster and more confident decisions rather than simply more data output.

The direction of travel for CROs

Looking ahead, Mary expects continued sponsor consolidation, margin pressure, and higher inspection intensity across the CRO sector. She highlights outcome-based contracting and more integrated platform CRO models as emerging directions. Her core view is that the next phase of CRO advantage will be defined less by size and more by governance strength, leadership depth, and consistent execution credibility.

In conclusion, Mary Gunn highlights that CRO success is increasingly defined by execution credibility, governance strength, and leadership depth - not scale alone. As sponsor expectations and trial complexity rise, the organizations that lead will be those that deliver accountable, risk-aware execution and build truly strategic partnerships.